Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-28 12:36 pm Purchase | 2021-12-31 | 13G | Blue Owl Technology Finance Corp. OTF | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 25,239,104 12.600% | 25,239,104 (New Position) | Filing |
| 2022-10-28 11:24 am Purchase | 2021-12-31 | 13G | Blue Owl Technology Finance Corp. II | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 4,664,139 21.100% | 4,664,139 (New Position) | Filing |
| 2022-01-26 8:10 pm Purchase | 2021-12-31 | 13G | Surrozen, Inc. SRZN | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 138,764 5.940% | 138,764 (New Position) | Filing History |
| 2022-01-26 8:00 pm Sale | 2021-12-31 | 13G | Blue Owl Capital Corporation OBDC | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 32,157,815 8.180% | -10,533,028 (-24.67%) | Filing History |
| 2021-02-01 3:35 pm Sale | 2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 1.536% | -1,010,000 (-57.80%) | Filing History |
| 2021-02-01 3:30 pm Sale | 2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 140,280 4.489% | -27,500 (-16.39%) | Filing History |
| 2021-02-01 3:24 pm Sale | 2020-12-31 | 13G | Blue Owl Capital Corporation OBDC | REGENTS OF THE UNIVERSITY OF CALIFORNIA | 42,690,843 10.950% | -281,328 (-0.65%) | Filing History |